William S. Reardon, Director at IDERA PHARMACEUTICALS, INC. (IDRA), bought 13,561 shares at $1.82 ($25K) on 2013-09-16, disclosed to the SEC on 2013-09-17.
Open-market purchase of $25k IDRA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| HQL | BUY | 2014-07-01 | $4K | — | Filing → |
| SNTA | BUY | 2013-11-15 | $50K | — | Filing → |
| HQL | BUY | 2012-03-12 | $10K | — | Filing → |